Recalls & Warnings January 30, 2013 Seller of Omega-3 and Emu Oil Supplements Warned For Drug Claims, Misbranding On November 19, 2012, the FDA issued a warning letter to Emu Products & Management, Inc
Cardiovasc Diabetol 20:189
Its popularly used as a lip gloss too
veterans with Type 2 diabetes, initiation of semaglutide was associated with a twofold higher risk of incident NAION compared with initiation of an SGLT2 inhibitor. Findings like these have heightened awareness among medical professionals about monitoring vision in patients using GLP-1s
While this medication was initially designed to treat type 2 diabetes, Tirzepatide is now one of the most talked-about treatments for obesity and weight management
My position is somewhat complex